News

All medicine and health research in Norway has been evaluated by Norges forskningsråd in 2023-24 (aggregated report published April 8, 2025, link below). At the Institute for Cancer Research (ICR), Oslo University Hospital and Det medisinske fakultet UiO, our six research departments in ICR with >370 employees in 26 research groups, 29 project groups and seven core facility units were evaluated separately as six units (Cancer Genetics, Cancer Immunology, Molecular Cell Biology, Molecular Oncology, Radiation Biology, Tumor Biology). As Head of the ICR, I am very proud to say that our large and professional research organisation was evaluated as internationally excellent to outstanding on research quality, very strong to outstanding on organisation and with considerable to extensive societal impact!

The Institute for Cancer Research at Oslo University Hospital's Annual Report for 2024 is now available online and celebrates the institute's 70th Anniversary (founded in 1954). Alongside key figures and display of our outstanding research, we report on recruitment, training and career development, translation and innovation, dissemination, public outreach, and collaboration in Norway and abroad.

ICR groups are key partners in over 20 clinical trials and leaders in more than 120 translation and innovation projects, many of which involve collaborative efforts with industry partners. Our 370 employees in six research departments, 26 research groups, 29 project groups, and seven core facility units represent a vibrant environment and a fully-fledged cancer research organisation. Our staff's engagement in scientific and public discourse through talks, meetings, events, and media appearances underscores our proactive approach to knowledge dissemination and societal impact.

Read more in the Annual report here: Single page format - Double page format

Annual reports 2014 - 2024